Human-cell-derived organoids as a new ex vivo model for drug assays in oncology.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Drug Discovery Today

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.drudis.2018.02.003PMID 29428171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors

  2017cited by this paper
• Preclinical models of pancreatic ductal adenocarcinoma.

  2017cited by this paper
• Translational applications of adult stem cell-derived organoids

  2017cited by this paper
• Resolving drug effects in patient-derived cancer cells links organoid responses to genome alterations

  2017cited by this paper
• Human Primary Liver Cancer -derived Organoid Cultures for disease modelling and drug screening

  2017cited by this paper
• Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

  2017cited by this paper
• Next generation organoids for biomedical research and applications.

  2017cited by this paper
• Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery.

  2017cited by this paper
• Human tissues in a dish: The research and ethical implications of organoid technology

  2017cited by this paper
• Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer

  2016cited by this paper
• Three-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma

  2016cited by this paper
• A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.

  2016cited by this paper
• Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment

  2016cited by this paper
• Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions

  2016cited by this paper
• Reverse engineering liver buds through self-driven condensation and organization towards medical application.

  2016cited by this paper
• Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening

  2016cited by this paper
• Prospective derivation of a living organoid biobank of colorectal cancer patients.

  2015cited by this paper
• In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection.

  2015cited by this paper
• Organoid models of human and mouse ductal pancreatic cancer.

  2015cited by this paper
• Vascularized and Complex Organ Buds from Diverse Tissues via Mesenchymal Cell-Driven Condensation.

  2015cited by this paper
• Modeling mouse and human development using organoid cultures

  2015cited by this paper
• Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells.

  2015cited by this paper
• Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids

  2015cited by this paper
• Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro

  2015cited by this paper
• The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids

  2015cited by this paper
• Patient-derived models of acquired resistance can identify effective drug combinations for cancer

  2014cited by this paper
• Genome sequencing of normal cells reveals developmental lineages and mutational processes

  2014cited by this paper
• Identification of multipotent luminal progenitor cells in human prostate organoid cultures.

  2014cited by this paper
• Drug discovery through stem cell-based organoid models.

  2014cited by this paper
• Organogenesis in a dish: Modeling development and disease using organoid technologies

  2014cited by this paper
• Organoid cultures derived from patients with advanced prostate cancer.

  2014cited by this paper
• The tumour microenvironment in B cell lymphomas

  2014cited by this paper
• The biological and clinical challenge of liver cancer heterogeneity.

  2014cited by this paper
• Vascularized and functional human liver from an iPSC-derived organ bud transplant

  2013cited by this paper
• Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.

  2013cited by this paper
• Cerebral organoids model human brain development and microcephaly

  2013cited by this paper
• Phenotypic screens as a renewed approach for drug discovery.

  2013cited by this paper
• Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney

  2013cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• Ex vivo culture of human prostate tissue and drug development

  2013cited by this paper
• Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer

  2013cited by this paper
• What are the best routes to effectively model human colorectal cancer?

  2013cited by this paper
• Distinct levels of Sox9 expression mark colon epithelial stem cells that form colonoids in culture.

  2012cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012cited by this paper
• Patient-derived tumour xenografts as models for oncology drug development

  2012cited by this paper
• A nomenclature for intestinal in vitro cultures.

  2012cited by this paper
• Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.

  2011cited by this paper
• ABCG2 is a Direct Transcriptional Target of Hedgehog Signaling and Involved in Stroma-Induced Drug Tolerance in Diffuse Large B-Cell Lymphoma

  2011cited by this paper
• Crypt stem cells as the cells-of-origin of intestinal cancer

  2009cited by this paper
• Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche

  2009cited by this paper
• Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche

  2009cited by this paper
• Irinotecan in the treatment of colorectal cancer.

  2006cited by this paper
• BRAF mutation predicts sensitivity to MEK inhibition

  2006cited by this paper
• Matrigel: basement membrane matrix with biological activity.

  2005cited by this paper
• Expression and distribution of laminin alpha1 and alpha2 chains in embryonic and adult mouse tissues: an immunochemical approach.

  2002cited by this paper
• Human cancer cell lines: fact and fantasy

  2000cited by this paper
• Integrin-Mediated Drug Resistance in Multiple Myeloma

  2000cited by this paper
• Concordance of the toxicity of pharmaceuticals in humans and in animals.

  2000cited by this paper
• Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors.

  1991cited by this paper
• A murine tumor producing a matrix of basement membrane

  1977cited by this paper

• Model systems to study tumor-microbiome interactions in early-onset colorectal cancer

  2025cites this paper
• Intestinal organoids as advanced modeling platform for food research: a review

  2025cites this paper
• GSH/pH-Sensitive Poly(glycerol sebacate dithiodiglycolate) Nanoparticle as a Ferroptotic Inducer through Cooperation with Fe3+

  2024cites this paper
• Heterotypic tumor spheroids: a platform for nanomedicine evaluation

  2023cites this paper
• Construction of gigantic highly-porous microcarriers as a three-dimensional cell culture platform

  2023cites this paper
• Curcumin and Andrographis Exhibit Anti-Tumor Effects in Colorectal Cancer via Activation of Ferroptosis and Dual Suppression of Glutathione Peroxidase-4 and Ferroptosis Suppressor Protein-1

  2023cites this paper
• Patient‐Derived Microphysiological Systems for Precision Medicine

  2023cites this paper
• Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

  2023cites this paper
• An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening

  2022cites this paper
• Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models

  2021cites this paper
• Exploiting Intestinal Organoids and Foodomics Strategies for Studying the Role of Diet and Host Responses

  2021cites this paper
• Risk-benefit in food safety and nutrition - Outcome of the 2019 Parma Summer School.

  2021cites this paper
• Cellularized polymeric microarchitectures for drug screening

  2021cites this paper
• Decellularized micro-scaffolds as stem cell carriers for regeneration of cartilage defects

  2021cites this paper
• Size dependent regeneration capacity of functionalized Capra ear derived micro-tissue scaffolds for treatment of cartilage defects

  2021cites this paper
• Nanocomposite Gel as Injectable Therapeutic Scaffold: Microstructural Aspects and Bioactive Properties.

  2020cites this paper
• Padronização de cultura organoide para avaliação da melanogênese induzida por UVB, UVA e luz visível

  2020cites this paper
• Modeling Endothelialized Hepatic Tumor Microtissues for Drug Screening

  2020cites this paper
• Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies.

  2020cites this paper
• Intestinal Organoids: A Tool for Modelling Diet-Microbiome-Host Interactions.

  2020cites this paper
• A Tumor‐on‐a‐Chip System with Bioprinted Blood and Lymphatic Vessel Pair

  2019cites this paper
• Systems Pharmacology: Defining the Interactions of Drug Combinations.

  2019cites this paper
• Standardization of organoid culture for evaluation of melanogenesis induced by UVB, UVA and visible light☆☆☆

  2019cites this paper
• Recent Approaches Encompassing the Phenotypic Cell Heterogeneity for Anticancer Drug Efficacy Evaluation

  2019cites this paper
• Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review

  2019cites this paper
• A Brief Guide to Performing Pharmacological Studies In Vitro: Reflections from the EORTC-PAMM Course “Preclinical and Early-phase Clinical Pharmacology”

  2019cites this paper
• Gel with silver and ultrasmall iron oxide nanoparticles produced with Amanita muscaria extract: physicochemical characterization, microstructure analysis and anticancer properties

  2018cites this paper
• Organoïds: 3D Structures Emerging As A Promising Model For Drug Screening In Oncology

  2018cites this paper
• Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.

  2018cites this paper